Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-22-062858

Chief Commercial Officer sold 734 shares at $15.80 ($11,597)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wettig Thane Chief Commercial Officer 2022-12-23 Sale −734 $15.80 $11,597 89,163 D: show line 1 in the form
Open-market sales · 734 sh · avg $15.80 · $11,597
Loading xslF345X03/doc4.xml…